Enanta Pharmaceuticals Inc (NASDAQ: ENTA) is -33.16% lower on its value in year-to-date trading and has touched a low of $6.90 and a high of $17.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ENTA stock was last observed hovering at around $7.00 in the last trading session, with the day’s loss setting it -0.71%.
Currently trading at $6.29, the stock is -27.75% and -39.39% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.78 million and changing -10.14% at the moment leaves the stock -50.53% off its SMA200. ENTA registered -30.03% loss for a year compared to 6-month loss of -53.16%. The firm has a 50-day simple moving average (SMA 50) of $10.4771 and a 200-day simple moving average (SMA200) of $12.754325.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -40.99% gain in the last 1 month and extending the period to 3 months gives it a -49.40%, and is -21.47% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.18% over the week and 9.04% over the month.
Enanta Pharmaceuticals Inc (ENTA) has around 131 employees, a market worth around $133.31M and $67.64M in sales. Profit margin for the company is -171.58%. Distance from 52-week low is -8.84% and -64.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-36.39%).
with sales reaching $17.67M over the same period.The EPS is expected to grow by 14.44% this year, but quarterly earnings will post 7.15% year-over-year. Quarterly sales are estimated to shrink -1.87% in year-over-year returns.
154.0 institutions hold shares in Enanta Pharmaceuticals Inc (ENTA), with institutional investors hold 107.19% of the company’s shares. The shares outstanding are 21.19M, and float is at 19.72M with Short Float at 16.39%. Institutions hold 100.66% of the Float.
The top institutional shareholder in the company is FARALLON CAPITAL MANAGEMENT LLC with over 2.1 million shares valued at $27.17 million. The investor’s holdings represent 9.8914 of the ENTA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.93 million shares valued at $25.09 million to account for 9.1331 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 1.85 million shares representing 8.7229 and valued at over $23.96 million, while MORGAN STANLEY holds 6.877 of the shares totaling 1.46 million with a market value of $18.89 million.
Enanta Pharmaceuticals Inc (ENTA) Insider Activity
The most recent transaction is an insider sale by Kieffer Tara Lynn, the company’s Chief Product Strategy Officer. SEC filings show that Kieffer Tara Lynn sold 2,283 shares of the company’s common stock on Dec 06 ’24 at a price of $8.06 per share for a total of $18401.0. Following the sale, the insider now owns 29305.0 shares.
Enanta Pharmaceuticals Inc disclosed in a document filed with the SEC on Dec 06 ’24 that Luu Brendan (Chief Business Officer) sold a total of 2,283 shares of the company’s common stock. The trade occurred on Dec 06 ’24 and was made at $8.06 per share for $18401.0. Following the transaction, the insider now directly holds 36047.0 shares of the ENTA stock.
Still, SEC filings show that on Dec 06 ’24, Rottinghaus Scott T. (Chief Medical Officer) disposed off 866 shares at an average price of $8.06 for $6980.0. The insider now directly holds 17,918 shares of Enanta Pharmaceuticals Inc (ENTA).
